help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aoyama, T.
Right arrow Articles by Gonzalez, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aoyama, T.
Right arrow Articles by Gonzalez, F. J.

Endocrinology, Vol 126, 3101-3106, Copyright © 1990 by Endocrine Society

ARTICLES

Estradiol metabolism by complementary deoxyribonucleic acid-expressed human cytochrome P450s

T Aoyama, K Korzekwa, K Nagata, J Gillette, HV Gelboin and FJ Gonzalez
Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Twelve forms of human cytochrome P450 were synthesized in human hepatoma Hep G2 cells by means of cDNA-directed expression using vaccinia virus. The cDNA-expressed enzymes were tested for their ability to oxidize estradiol. Incubation of [14C]estradiol with cell lysates containing P450 IA2 resulted in the production of 2-hydroxy and 4-hydroxy metabolites with substrate turnovers of 2.74 and 0.27 min-1, respectively. P450s IIIA3 and IIIA4 yielded the same metabolites at about one third the rate of P450 IA2. Low levels of estradiol hydroxylation were also catalyzed by P450s IIC9, IIIA5, and IVB1. Six other P450 forms yielded no detectable metabolism. The roles of P450s IA2, IIA3, and IIIA4 were further established by immunoinhibition using antirat P450 antibodies. Antibody that specifically binds to P450 IIIA3 and IIIA4 inhibited 60-70% of estradiol hydroxylation, and antibody against P450 IA2 inhibited 20-40% of the estradiol hydroxylase activity in microsomes from two human liver specimens, suggesting that these enzymes constitute the major forms catalyzing estradiol oxidation in human liver. Immunoinhibition results also suggest that 2-hydroxy- and/or 4-hydroxycatechol estrogens are further metabolized to other yet uncharacterized metabolites by P450s IIIA3 and IIIA4.


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
M. Rahman, S. F. Lax, C. H. Sutter, Q. T. Tran, G. L. Stevens, G. L. Emmert, J. Russo, R. J. Santen, and T. R. Sutter
CYP1B1 Is Not a Major Determinant of the Disposition of Aromatase Inhibitors in Epithelial Cells of Invasive Ductal Carcinoma
Drug Metab. Dispos., May 1, 2008; 36(5): 963 - 970.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
J. M. Hamilton-Reeves, S. A. Rebello, W. Thomas, J. W. Slaton, and M. S. Kurzer
Soy Protein Isolate Increases Urinary Estrogens and the Ratio of 2:16{alpha}-Hydroxyestrone in Men at High Risk of Prostate Cancer
J. Nutr., October 1, 2007; 137(10): 2258 - 2263.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
M. J. Karjalainen, P. J. Neuvonen, and J. T. Backman
Rofecoxib Is a Potent, Metabolism-Dependent Inhibitor of CYP1A2: Implications for in Vitro Prediction of Drug Interactions
Drug Metab. Dispos., December 1, 2006; 34(12): 2091 - 2096.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. R. Starr, C. Chen, D. R. Doody, L. Hsu, S. Ricks, N. S. Weiss, and S. M. Schwartz
Risk of Testicular Germ Cell Cancer in Relation to Variation in Maternal and Offspring Cytochrome P450 Genes Involved in Catechol Estrogen Metabolism
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2183 - 2190.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A.-M. Yu, K. Fukamachi, K. W. Krausz, C. Cheung, and F. J. Gonzalez
Potential Role for Human Cytochrome P450 3A4 in Estradiol Homeostasis
Endocrinology, July 1, 2005; 146(7): 2911 - 2919.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
M. Delaforge, A. Pruvost, L. Perrin, and F. Andre
CYTOCHROME P450-MEDIATED OXIDATION OF GLUCURONIDE DERIVATIVES: EXAMPLE OF ESTRADIOL-17{beta}-GLUCURONIDE OXIDATION TO 2-HYDROXY-ESTRADIOL-17{beta}-GLUCURONIDE BY CYP 2C8
Drug Metab. Dispos., March 1, 2005; 33(3): 466 - 473.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
A. J. Lee and B. T. Zhu
NADPH-DEPENDENT FORMATION OF POLAR AND NONPOLAR ESTROGEN METABOLITES FOLLOWING INCUBATIONS OF 17{beta}-ESTRADIOL WITH HUMAN LIVER MICROSOMES
Drug Metab. Dispos., August 1, 2004; 32(8): 876 - 883.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K. Vistisen, S. Loft, J. H. Olsen, S. Vallentin, S. Ottesen, F. R. Hirsch, and H. E. Poulsen
Low CYP1A2 activity associated with testicular cancer
Carcinogenesis, June 1, 2004; 25(6): 923 - 929.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. J. Lee, M. X. Cai, P. E. Thomas, A. H. Conney, and B. T. Zhu
Characterization of the Oxidative Metabolites of 17{beta}-Estradiol and Estrone Formed by 15 Selectively Expressed Human Cytochrome P450 Isoforms
Endocrinology, August 1, 2003; 144(8): 3382 - 3398.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
M. A. Sarkar, V. Vadlamuri, S. Ghosh, and D. D. Glover
Expression and Cyclic Variability of CYP3A4 and CYP3A7 Isoforms in Human Endometrium and Cervix During the Menstrual Cycle
Drug Metab. Dispos., January 1, 2003; 31(1): 1 - 6.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
A. E. M. Vickers, M. Zollinger, R. Dannecker, R. Tynes, F. Heitz, and V. Fischer
In Vitro Metabolism of Tegaserod in Human Liver and Intestine: Assessment of Drug Interactions
Drug Metab. Dispos., October 1, 2001; 29(10): 1269 - 1276.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. J. Lee, J. W. Kosh, A. H. Conney, and B. T. Zhu
Characterization of the NADPH-Dependent Metabolism of 17beta -Estradiol to Multiple Metabolites by Human Liver Microsomes and Selectively Expressed Human Cytochrome P450 3A4 and 3A5
J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 420 - 432.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
D. F. McGinnity, A. J. Parker, M. Soars, and R. J. Riley
Automated Definition of the Enzymology of Drug Oxidation by the Major Human Drug Metabolizing Cytochrome P450s
Drug Metab. Dispos., November 1, 2000; 28(11): 1327 - 1334.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
I. H. Hanna, S. Dawling, N. Roodi, F. P. Guengerich, and F. F. Parl
Cytochrome P450 1B1 (CYP1B1) Pharmacogenetics: Association of Polymorphisms with Functional Differences in Estrogen Hydroxylation Activity
Cancer Res., July 1, 2000; 60(13): 3440 - 3444.
[Abstract] [Full Text]

Home page
 J Natl Cancer Inst MonogrHome page
C. R. Jefcoate, J. G. Liehr, R. J. Santen, T. R. Sutter, J. D. Yager, W. Yue, S. J. Santner, R. Tekmal, L. Demers, R. Pauley, et al.
Chapter 5: Tissue-Specific Synthesis and Oxidative Metabolism of Estrogens
J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 95 - 112.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Zhang, Q.-Y. Zhang, J. Guo, Y. Zhou, and X. Ding
Identification and Functional Characterization of a Conserved, Nuclear Factor 1-like Element in the Proximal Promoter Region of CYP1A2 Gene Specifically Expressed in the Liver and Olfactory Mucosa
J. Biol. Chem., March 17, 2000; 275(12): 8895 - 8902.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. G. Liehr
Is Estradiol a Genotoxic Mutagenic Carcinogen?
Endocr. Rev., February 1, 2000; 21(1): 40 - 54.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
X. Xu, A. M. Duncan, B. E. Merz-Demlow, W. R. Phipps, and M. S. Kurzer
Menstrual Cycle Effects on Urinary Estrogen Metabolites
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3914 - 3918.
[Abstract] [Full Text]

Home page
 Drug Metab. Dispos.Home page
D. F. McGinnity, S. J. Griffin, G. C. Moody, M. Voice, S. Hanlon, T. Friedberg, and R. J. Riley
Rapid Characterization of the Major Drug-Metabolizing Human Hepatic Cytochrome P-450 Enzymes Expressed in Escherichia coli
Drug Metab. Dispos., September 1, 1999; 27(9): 1017 - 1023.
[Abstract] [Full Text]

Home page
 Am. J. Clin. Nutr.Home page
J. W Lampe
Health effects of vegetables and fruit: assessing mechanisms of action in human experimental studies
Am. J. Clinical Nutrition, September 1, 1999; 70(3): 475S - 490.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S. S. Dehal and D. Kupfer
Cytochrome P-450 3A and 2D6 Catalyze Ortho Hydroxylation of 4-Hydroxytamoxifen and 3-Hydroxytamoxifen (Droloxifene) Yielding Tamoxifen Catechol: Involvement of Catechols in Covalent Binding to Hepatic Proteins
Drug Metab. Dispos., June 1, 1999; 27(6): 681 - 688.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
D. M. Gentile, C. H. J. Verhoeven, T. Shimada, and D. J. Back
The Role of CYP2C in the In Vitro Bioactivation of the Contraceptive Steroid Desogestrel
J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 975 - 982.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Liddle, B. J. Goodwin, J. George, M. Tapner, and G. C. Farrell
Separate and Interactive Regulation of Cytochrome P450 3A4 by Triiodothyronine, Dexamethasone, and Growth Hormone in Cultured Hepatocytes
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2411 - 2416.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
D. Wu and A. I. Cederbaum
Ethanol Cytotoxicity to a Transfected HepG2 Cell Line Expressing Human Cytochrome P4502E1
J. Biol. Chem., September 27, 1996; 271(39): 23914 - 23919.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society